Paid Clinical Trials Oregon

Discover 1,130 paid clinical trials in Oregon. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,130

AspirinUsing Aspirin to Improve Immunological Features of Ovarian Tumors

Recruiting

EARLY_PHASE1

Sponsor:

H. Lee Moffitt Cancer Center and Research Institute

Location:

Portland OR, Charlottesville VA, Fairfax VA, Tampa FL

Code:

NCT05080946

Conditions

Ovarian Cancer

Fallopian Tube Cancer

Peritoneal Cancer

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Aspirin 325mg

Placebo

MRI AssessmentQuantitative MRI Assessment of Breast Cancer Therapy Response

Recruiting

Sponsor:

OHSU Knight Cancer Institute

Location:

Portland OR, Seattle WA, Iowa City IA

Code:

NCT05704062

Conditions

Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Diffusion Weighted Imaging

Dynamic Contrast-Enhanced Magnetic Resonance Imaging

LY3556050A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain

Recruiting

PHASE2

Sponsor:

Eli Lilly and Company

Location:

Medford OR, Renton WA, Bellevue WA, Sacramento CAshow 29 more

Code:

NCT06074562

Conditions

Diabetic Peripheral Neuropathy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

LY3556050

Placebo

Observational StudyRural Community Peer Partnerships for Improving Methamphetamine-Associated Heart Failure Screening and Engagement

Recruiting

Sponsor:

Oregon Health and Science University

Location:

Portland OR

Code:

NCT06461962

Conditions

Methamphetamine Use

Heart Failure

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Treatment as Usual

Telehealth-Cardiology

Crenolanib vs. MidostaurinStudy of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML

Recruiting

PHASE3

Sponsor:

Arog Pharmaceuticals, Inc.

Location:

Portland OR, Sacramento CA, Duarte CA, Los Angeles CAshow 17 more

Code:

NCT03258931

Conditions

Newly Diagnosed FLT3 Mutated AML

Eligibility Criteria

Sex: All

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Crenolanib

Midostaurin

Cytarabine

Duanorubicin

Skeletal Muscle PerfusionSkeletal Muscle Perfusion With LVAD

Recruiting

Sponsor:

Oregon Health and Science University

Location:

Portland OR

Code:

NCT02105831

Conditions

Heart Failure

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Contrast ultrasound skeletal muscle perfusion imaging

MetforminMetformin Use in Patients Undergoing Total Joint Replacement Surgery

Recruiting

Sponsor:

Oregon Health and Science University

Location:

Portland OR

Code:

NCT06280274

Conditions

Hyperglycemia

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Metformin

Placebo

Biofeedback-Based RehabilitationWearable Technology to Characterize and Treat mTBI Subtypes: Biofeedback-Based Precision Rehabilitation

Recruiting

Sponsor:

Oregon Health and Science University

Location:

Portland OR, Salt Lake City UT, San Antonio TX

Code:

NCT06381674

Conditions

Mild Traumatic Brain Injury, Concussion

Rehabilitation

Balance Impairment

Eligibility Criteria

Sex: All

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Vestibular therapy for mTBI augmented with audio and visual real-time biofeedback

Vestibular therapy for mTBI

IbrutinibA Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia

Recruiting

PHASE2

Sponsor:

Janssen Research & Development, LLC

Location:

Eugene OR, Portland OR, Vancouver WA, Seattle WAshow 29 more

Code:

NCT05963074

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell

Small Lymphocytic Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ibrutinib

Venetoclax

Chemotherapy with Endocrine TherapyEvaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Redmond OR, Bend OR, Oregon City OR, Clackamas ORshow 715 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

Popular cities in Oregon

Eugene Salem Portland